Sandra Misale
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Oncology 18
- Colorectal Cancer Treatments and Studies 12
- HER2/EGFR in Cancer Research 5
- Cytokine Signaling Pathways and Interactions 2
- Cancer-related Molecular Pathways 2
-
- Lung Cancer Treatments and Mutations 9
- Co-authors
- Alberto Bardelli (10 shared papers)Federica Di Nicolantonio (9 shared papers)Salvatore Siena (4 shared papers)Andrea Sartore‐Bianchi (4 shared papers)Sebastijan Hobor (3 shared papers)Alice Lallo (3 shared papers)Giulia Siravegna (5 shared papers)Luca Lazzari (3 shared papers)
- Journals
- Cancer Research (3 papers)Cancer Discovery (3 papers)Molecular Cancer Therapeutics (2 papers)Science Translational Medicine (2 papers)Nature Cancer (2 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Sandra Misale
21 papers receiving 1.1k citations
Sandra Misale's Hit Papers
Peers
Comparison fields: 5 of 67
- Cancer Research 437
- Oncology 730
- Pathology and Forensic Medicine 242
- Pulmonary and Respiratory Medicine 283
- Hepatology 67
Countries citing papers authored by Sandra Misale
This map shows the geographic impact of Sandra Misale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Misale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Misale more than expected).
Fields of papers citing papers by Sandra Misale
This network shows the impact of papers produced by Sandra Misale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Misale. The network helps show where Sandra Misale may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra Misale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Resistance to Anti-EGFR Therapy in Colorectal Cancer: From Heterogeneity to Convergent Evolution Hit paper breakdown → | 2014 | 374 |
| 2 | 2014 | 195 | |
| 3 | 2019 | 151 | |
| 4 | 2015 | 91 | |
| 5 | 2014 | 84 | |
| 6 | 2016 | 76 | |
| 7 | 2012 | 51 | |
| 8 | 2018 | 24 | |
| 9 | 2024 | 12 | |
| 10 | 2023 | 7 | |
| 11 | Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of | 2014 | 4 |
| 12 | 2024 | 3 | |
| 13 | 2014 | 2 | |
| 14 | 2012 | 2 | |
| 15 | 2024 | 1 | |
| 16 | 2023 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2013 | 1 | |
| 19 | 2017 | 1 | |
| 20 | 2015 | 1 |
About Sandra Misale
Sandra Misale is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Biotechnology, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (12 papers), Lung Cancer Treatments and Mutations (9 papers), Cancer Genomics and Diagnostics (7 papers), HER2/EGFR in Cancer Research (5 papers), Melanoma and MAPK Pathways (4 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Cancer Research (437 citations), Oncology (730 citations), Pathology and Forensic Medicine (242 citations), Pulmonary and Respiratory Medicine (283 citations) and Hepatology (67 citations). Sandra Misale has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Alberto Bardelli, Federica Di Nicolantonio, Salvatore Siena, Andrea Sartore‐Bianchi, Sebastijan Hobor, Alice Lallo, Giulia Siravegna, Luca Lazzari, Sabrina Arena and Beth O. Van Emburgh. Their work appears in journals such as Cancer Research, Cancer Discovery, Molecular Cancer Therapeutics, Science Translational Medicine and Nature Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.